Mintarc vs Biotech Pulse
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Mintarc
Read full descriptionHide full description
Take control of your collection with Mintarc, the premier portfolio manager for adult fans of LEGO® (AFOL). Why Mintarc? Most trackers only show "vanity" prices. Mintarc uses professional-grade logic to show you exactly how much money you’ve made. CORE FEATURES: • REAL-TIME RETIREMENT TRACKER: Stay ahead of the "End of Life" (EOL) dates. Know exactly when sets are leaving shelves so you can buy before the secondary market spike. • MINIFIGURE UNPACKING: Automatically track the individual value of every minifigure inside your sets. Watch your "Troop Count" and see which characters are mooning. • PORTFOLIO ANALYTICS: View your equity growth over time with clean, geometric data visualizations. LEGAL COMPLIANCE: Mintarc is a dedicated information tool. LEGO® is a trademark of the LEGO Group of companies which does not sponsor, authorize, or endorse this application. INVESTMENT DISCLAIMER: All data is for informational purposes. Collectibles are volatile assets. Mintarc does not provide financial or tax advice. Please conduct your own due diligence. Pricing data is powered by independent market analysis and third-party APIs. Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Biotech Pulse
Access real-time biotech industry intelligence, including FDA approvals, PDUFA dates, and SEC filings. Stay ahead of market news with instant alerts and detailed company and drug information. Ideal for investors and analysts seeking an edge in the fast-paced biotech sector.
- Real-time FDA approval and PDUFA date alerts
- EU EMA marketing authorisation feed
- SEC filings and clinical trial updates
- Forward catalyst calendar
- Push notifications for watchlisted tickers
- Insider buys and institutional holdings (Pro)
- Patent timelines and drug shortages (Pro)
Read full descriptionHide full description
The biotech catalyst tracker for serious investors. Real-time FDA approvals, PDUFA dates, EMA and CHMP committee opinions, SEC filings, clinical trial readouts, and primary-source company news — pushed the moment they hit the regulatory record. WHO IT'S FOR Biotech investors, pharma analysts, healthcare hedge funds, and retail traders who need to see what just happened on a name BEFORE the wire-service summary hits Twitter. FREE FEATURES (no account, no signup) • Real-time FDA approval, PDUFA, CRL, and Warning Letter alerts • EU EMA marketing authorisation feed (UK + EEA centralised approvals) • SEC 8-K filings, press releases, and clinical trial updates • Forward catalyst calendar with PDUFA, AdCom, and CHMP dates • Push notifications when a watchlisted ticker has an event • Watchlist + per-ticker News, Pipeline, Drugs, Intelligence tabs • Indication / drug-class search ("multiple sclerosis", "GLP-1", "CAR-T") • Drug detail with FAERS adverse-event severity and primary-source link to Drugs@FDA • Watchlist Compare view — side-by-side pipeline depth + next catalyst BIOTECH PULSE PRO ($9.99/mo or $79.99/yr, with 7-day free trial) Twelve institutional-grade Pro features, every one sourced from a primary regulatory or scientific feed: • Insider buys — SEC Form 4 executive open-market purchases, 10b5-1 plans filtered out • 13F institutional holdings — quarterly changes, biotech-whale callouts (Baker Bros, BVF, RA Capital, Perceptive) • 8-K dilution radar — automatic offering / shelf / ATM classification • 8-K Item 8.01 content classifier — CRL, PDUFA, AdCom, trial readout, partnership, regulatory filing categories • Material agreements — 8-K Item 1.01 partnership / licensing / supply detection • AdCom calendar — Federal Register FDA Advisory Committee meetings + briefing-doc URLs • Orange Book + USPTO patent timelines — every unexpired patent with USPTO Patent Term Adjustment chips (PTA extends patent expiry past the Orange Book listing — the most under-priced biotech signal), Re-exam warning flags, family-size hints, and one-tap to the patent document on Google Patents • FDA Warning Letter history • FDA device clearances — 510(k) and PMA by manufacturer • DailyMed label history — every SPL version bump (indication, black-box, REMS) • CMS Open Payments — KOL payment network per sponsor • CMS Part D utilization — 5 years of Medicare prescription volume • Drug shortages — FDA-tracked active shortages with push alerts on status changes • Conference abstracts — ASH, ASCO, AHA, AAN, DDW • Custom alert rules — unlimited, all 4 trigger types including 8-K Item filtering 100% PRIMARY-SOURCE DATA SEC EDGAR. openFDA. EMA. CHMP. Health Canada. CMS. NIH. Federal Register. ClinicalTrials.gov. DailyMed. USPTO. ash.confex.com. No Bloomberg, no Refinitiv, no FactSet, no paid data vendors. No AI hallucinations. No analyst recommendations. Just the data. NO TRACKING No analytics SDK. No advertising SDK. No cross-app tracking. No account required. External article links open in Safari's isolated process. We don't know who you are. Pro auto-renews unless cancelled at least 24 hours before the end of the current period. Cancel anytime in iOS Settings → Apple ID → Subscriptions. Terms of Use: https://bioturd.com/terms Privacy Policy: https://bioturd.com/privacy
Screenshots
Verdict
The clearest difference is in-app purchases: Mintarc at none against Biotech Pulse's 2. Biotech Pulse's advantage is ads (none vs shown). On price, update cadence, device support and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Biotech Pulse sells 2 in-app purchases, starting at $14.99 per month. Mintarc asks for nothing beyond the download.
Mintarc ships an update every 10 days, Biotech Pulse weekly. Both last shipped on November 15, 2026.
| Parameter | Mintarc | Biotech Pulse |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (5 ratings) — better |
| Number of ratings | — | 5 — better |
| Update frequency | Every 10 days | Weekly — better |
| Ads | Yes | No — better |
| In-app purchases | No — better | Yes |
| Monetization | — | Freemium |
| Devices | iPhone, iPad, iPod — better | iPhone, iPod |
| Requires iOS | 15.1 | 15.1 |
| Further details — not scored | ||
| Size | 66 MB | 37 MB |
| Age rating | 4+ | 4+ |
| Developer | sebastian chew | MEAS Partners, LLC |
In-app purchases
Mintarc
No in-app purchases
Biotech Pulse
- Biotech Pulse Pro$14.991 Month
- Biotech Pulse Pro7 Days trial$119.001 Year









